Guided Therapeutics (GTHP) Shares Outstanding (2010 - 2026)

Guided Therapeutics has reported Shares Outstanding (Entity) for 16 years, with the latest figure at $86.2 million in Q4 2025.

• Quarterly Shares Outstanding (Entity) rose 32.28% year-over-year to $86.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $86.2 million (up 32.28% YoY) and the FY2025 annual result came in at $86.2 million, up 32.28% from the prior year.
• Shares Outstanding (Entity) improved to $86.2 million in Q4 2025 per GTHP's latest filing, from $83.6 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $86.2 million in Q4 2025 and troughed at $13180.0 in Q1 2021.
• A 5-year average of $43.7 million and a median of $50.9 million in 2023 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Entity) jumped 169217.15% in 2022, then tumbled 99.89% in 2024.
• Over 5 years, Shares Outstanding (Entity) stood at $13.7 million in 2021, then soared by 137.73% to $32.5 million in 2022, then soared by 66.45% to $54.1 million in 2023, then rose by 20.38% to $65.1 million in 2024, then surged by 32.28% to $86.2 million in 2025.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $86.2 million, $83.6 million, and $79.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.